Multi Commodity Exchange of India (MCX) shares are likely to remain in focus after global brokerage UBS downgraded the stock to ‘Neutral’ from ‘Buy’, even as it raised its target price to ₹3,600 from ₹3,200.
The brokerage said that while the commodity exchange continues to benefit from elevated trading activity and healthy volumes, much of the positive outlook appears to be reflected in the stock price following its sharp rally this year.
UBS noted that volatility across key commodities has remained elevated in recent months, supporting trading activity on the exchange. The brokerage also highlighted that MCX has reported healthy volumes in Q1FY27 so far, although activity has normalised from the exceptionally strong levels seen during the March quarter.
Despite the robust operating environment, UBS believes peak earnings momentum may now be behind the company. According to the brokerage, the stock is currently trading at around 50 times one-year forward earnings, approximately 10% above its historical average valuation, limiting the scope for further re-rating.
The brokerage added that it is not concerned about competitive pressures at this stage and does not see any immediate threat to MCX’s dominant position in India’s commodity derivatives market. However, UBS believes the market has already priced in the strong volume run-rate and future earnings growth potential.
As a result, while the brokerage increased its target price to ₹3,600 to reflect stronger business fundamentals and earnings expectations, it downgraded the stock to Neutral, citing limited upside from current levels.
MCX has been among the standout performers in the Indian market this year. Shares of the commodity exchange have gained nearly 44% on a year-to-date basis and were trading at ₹3,155 on May 27. The stock remains close to its 52-week high of ₹3,480 and commands a market capitalisation of over ₹80,000 crore.
Investors will now closely track commodity market volatility, trading volumes and any regulatory developments that could influence the exchange’s growth trajectory over the coming quarters.
Disclaimer: The views and recommendations are those of UBS and do not represent the views of the publication. This article is for informational purposes only and should not be construed as investment advice.